STATEMENT TO
[First Reprint]
ASSEMBLY, No. 4163
with Senate Floor Amendments
(Proposed by Senator GOPAL)
ADOPTED: MARCH 24, 2025
This floor amendment:
(1) modifies the coverage to be provided by health insurers under the bill to include coverage for biomarker precision medical testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of a disease or condition;
(2) clarifies the circumstances under which biomarker precision medical testing is required to be covered;
(3) adds language requiring certain insurers to provide coverage for biomarker precision medical testing to the same extent as for other medical conditions, including clinical review criteria used for utilization review of health care services and copayment, deductible, and coinsurance provisions; and
(4) makes technical changes.